适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 主要终点
- Safety analysis will include all subjects who receive at least one dose of study drug
研究概览
简要总结
The objective of this study is to provide Maraviroc on a compassionate use basis to antiretroviral treatment experienced patients infected with CCR5-tropic HIV-1 with urgent unmet medical needs and who, in the opinion of the physician, require Maraviroc to form a viable regimen.
详细描述
This study was cancelled prior to enrollment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients at least 16 years old with prior extensive treatment experience with limited further options in need of maraviroc to constitute an effective HIV-1 treatment regimen.
- •Have only CCR5-tropic HIV-1 virus
- •CD4+ cell count < 200 cells/mm3
排除标准
- •CXCR4- or dual/mixed-tropic HIV-1 virus
- •Patients who in the opinion of investigator are unlikely to derive benefit from maraviroc as a result of severity of illness
- •Patients who are pregnant or breast feeding an infant or planning to become pregnant.
研究组 & 干预措施
1
Other
干预措施: Maraviroc (Drug)
结局指标
主要结局
Safety analysis will include all subjects who receive at least one dose of study drug
时间窗: Two Years
次要结局
- Safety analysis will include all subjects who receive at least one dose of study drug(Two years)
研究者
相似试验
No Longer Available
不适用
A Compassionate Access Protocol For Those Patients Who Have Completed A4001029HIVNCT00801515ViiV Healthcare
已完成
不适用
Prospective Observational Epidemiologic Study of Maraviroc's SafetyHuman Immunodeficiency VirusNCT00665561ViiV Healthcare2,500
终止
2 期
Maraviroc in Rheumatoid ArthritisArthritis, RheumatoidNCT00427934Pfizer128
Approved For Marketing
不适用
Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver DiseaseCholestasisLiver DiseasesNCT03072667Catherine Cibulskis, MD
已完成
2 期
A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected PatientsHuman Immunodeficiency Virus-1NCT00827112ViiV Healthcare129